Blueprint Medicines

Blueprint Medicines

Blueprint Medicines

Blueprint Medicines discovers and develops highly selective kinase inhibitors for patients with genomically defined cancers
Founded
2011
Raised
$240M
Follow us
Alexa global traffic share
Twitter followers
08 Dec 2016
$125,000,000
Post-IPO debt

Biotech Day on Twitter

Twitter
12 Nov 2014
$50,000,000
Venture capital (Series C)
07 Jan 2014
$25,000,000
Venture capital (Series B)
11 Apr 2011
$40,000,000
Venture capital (Series A)